Pay in 4 interest-free payments of $6.14 Learn more
Ships within 48 hours · Estimated delivery Nov 11 - Nov 16
Expanded Regulatory Approvals for CVD Risk Reduction The FDA cleared Wegovys cardiovascular label in March 2024, following the publication of the SELECT trial results, which showed a 20% relative risk reduction in major adverse cardiovascular events
The robust 5 per cent from the SURMOUNT trials remains the most reliable figure
If a drug has a boxed warning it means it carries risks of severe harm or death
According to the SmPC, if a patient does not tolerate a dose increase, delaying the increase by an additional 4 weeks can be considered
Understanding your specific formulation's storage requirements may help provide context for how to maintain medication integrity throughout your treatment course
US$ 24.89
US$ 25.12
US$ 24.70
US$ 27.12
US$ 25.56
